PFIZER INC·4

Mar 5, 5:26 PM ET

Denton David M 4

4 · PFIZER INC · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
Denton David M
Chief Financial Officer & EVP
Transactions
  • Award

    Stock Appreciation Rights

    [F1]
    2026-03-03+216,537216,537 total
    Exercise: $26.58From: 2031-03-03Exp: 2031-03-03Common Stock (216,537 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Signature
/s/ Shanice A. Reid, by power of atty, for David M. Denton|2026-03-05

Documents

1 file
  • 4
    doc4.xmlPrimary